16:09 EST Voyager Therapeutics (VYGR) files $400M mixed securities shelf
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VYGR:
- Voyager Therapeutics price target lowered to $11 from $12 at Leerink
- Voyager Therapeutics reports Q3 EPS (47c), consensus (52c)
- Voyager Therapeutics expects cash to fund operations into 2028
- Voyager Therapeutics, Transition Bio entered into drug discovery collab
- Voyager Therapeutics Advances Alzheimer’s Study with VY7523